Imaging features, therapies, and outcomes of fibrosing inflammatory pseudotumor of the nasopharynx: A systematic review

2021 ◽  
Author(s):  
Shruti Mishra ◽  
Chong Hyun Suh ◽  
Regan W Bergmark ◽  
Vickie Y Jo ◽  
Edison K Miyawaki ◽  
...  
2014 ◽  
Vol 125 (4) ◽  
pp. 813-821 ◽  
Author(s):  
Stuti V. Desai ◽  
Eleonora F. Spinazzi ◽  
Christina H. Fang ◽  
Grace Huang ◽  
Senja Tomovic ◽  
...  

2014 ◽  
Vol 23 (8) ◽  
pp. 1464-1483 ◽  
Author(s):  
Sjoerd G. Elias ◽  
Arthur Adams ◽  
Dorota J. Wisner ◽  
Laura J. Esserman ◽  
Laura J. van't Veer ◽  
...  

2020 ◽  
Vol 40 (4) ◽  
pp. 424-431
Author(s):  
Francesca Bascietto ◽  
Asma Khalil ◽  
Giuseppe Rizzo ◽  
Alexander Makatsariya ◽  
Danilo Buca ◽  
...  

2020 ◽  
Vol 34 ◽  
pp. 101623 ◽  
Author(s):  
Alfonso J. Rodriguez-Morales ◽  
Jaime A. Cardona-Ospina ◽  
Estefanía Gutiérrez-Ocampo ◽  
Rhuvi Villamizar-Peña ◽  
Yeimer Holguin-Rivera ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0187386
Author(s):  
Neshika Samarasekera ◽  
Mark Alexander Rodrigues ◽  
Pheng Shiew Toh ◽  
Rustam Al-Shahi Salman

2007 ◽  
Vol 188 (1) ◽  
pp. W44-W48 ◽  
Author(s):  
Mitchell E. Tublin ◽  
A. James Moser ◽  
J. Wallis Marsh ◽  
Thomas Clark Gamblin

2021 ◽  
Author(s):  
Benjamin Victor Ineichen ◽  
Charidimos Tsagkas ◽  
Martina Absinta ◽  
Daniel S Reich

Background: The lack of systematic evidence on leptomeningeal enhancement (LME) on MRI in neurological diseases, including multiple sclerosis (MS), hampers its interpretation in clinical routine and research settings. Purpose: To perform a systematic review and meta-analysis of MRI LME in MS and other neurologi-cal diseases. Materials and Methods: In a comprehensive literature search in Medline, Scopus, and Embase, out of 2292 publications, 459 records assessing LME in neurological diseases were eligible for qualitative synthesis. Of these, 135 were included in a random effects model meta-analysis with subgroup analyses for MS. Results: Of eligible publications, 161 investigated LME in neoplastic neurological (n=2392), 91 in neuroinfectious (n=1890), and 75 in primary neuroinflammatory diseases (n=4038). The LME proportions for these disease classes were 0.47 [95%CI: 0.37 to 0.57], 0.59 [95%CI: 0.47 to 0.69], and 0.26 [95%CI: 0.20 to 0.35], respectively. In a subgroup analysis comprising 1605 MS cases, LME proportion was 0.30 [95%CI 0.21 to 0.42] with lower proportions in relapsing-remitting (0.19 [95%CI 0.13 to 0.27]) compared to progressive MS (0.39 [95%CI 0.30 to 0.49], p=0.002) and higher proportions in studies imaging at 7T (0.79 [95%CI 0.64 to 0.89]) compared to lower field strengths (0.21 [95%CI 0.15 to 0.29], p<0.001). LME in MS was associated with longer disease duration (mean difference 2.2 years [95%CI 0.2 to 4.2], p=0.03), higher Expanded Disability Status Scale (mean difference 0.6 points [95%CI 0.2 to 1.0], p=0.006), higher T1 (mean difference 1.6ml [95%CI 0.1 to 3.0], p=0.04) and T2 lesion load (mean difference 5.9ml [95%CI 3.2 to 8.6], p<0.001), and lower cortical volume (mean difference -21.3ml [95%CI -34.7 to -7.9], p=0.002). Conclusions: Our study provides high-grade evidence for the substantial presence of LME in MS and a comprehensive panel of other neurological diseases. Our data could facilitate differential diagnosis of LME in clinical settings. Additionally, our meta-analysis corroborates that LME is associ-ated with key clinical and imaging features of MS. PROSPERO No: CRD42021235026.


2021 ◽  
pp. 20201220
Author(s):  
Lokesh Agarwal ◽  
Ayushi Agarwal ◽  
Shailesh Advani ◽  
Varidh Katiyar ◽  
Aprajita Chaturvedi ◽  
...  

Objectives: With the increasing recognition of gastrointestinal (GI) manifestation of coronavirus disease-19 (COVID-19), various abdominal imaging findings are increasingly being noted. We scoped the existing literature on the abdominal imaging findings in COVID-19. Methods: A systematic literature search was performed on PubMed, Embase, Google scholar and World Health Organization COVID-19 database. Results: 35 studies were included in the final descriptive synthesis. Among the studies reporting positive abdominal imaging findings in patients with COVID-19, majority described imaging abnormalities of the GI tract (16 studies), of which bowel wall thickening was most frequently reported. Other findings noted were abdominal imaging manifestations of bowel ischemia with thrombosis of the splanchnic vasculature, and imaging features suggestive of pancreatitis. Imaging findings suggestive of solid organ infarction were reported in nine studies. An association between imaging evidence of hepatic steatosis and COVID-19 was noted in three studies. Incidental lung base findings on abdominal imaging were noted in 18 studies, where patients presented with predominant GI symptoms. The most common finding was bilateral ground glass opacities (90.7%) with predominant multilobar (91.1%) and peripheral (64.4%) distribution. Conclusion: This systematic review provides insight into the abdominal imaging findings in patients with COVID-19. Knowledge of these imaging manifestations will not only help in further research but also will aid in curtailing transmission of the SARS-CoV-2. Further prospective studies are needed to gain better insight into the pathophysiology of these imaging manifestations. Advances in knowledge: This review highlights the abdominal imaging findings in patients with COVID-19, to gain insight into the disease pathophysiology and gear the abdominal radiologist through the pandemic.


2020 ◽  
Vol 56 (1) ◽  
pp. 252-263
Author(s):  
Gustavo Nino ◽  
Jonathan Zember ◽  
Ramon Sanchez‐Jacob ◽  
Maria J. Gutierrez ◽  
Karun Sharma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document